- Home
- CLNN vs TBHC Comparison
CLNN vs TBHC Comparison
Compare CLNN & TBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- TBHC
- Stock Information
- Founded
- CLNN 2012
- TBHC 1966
- Country
- CLNN United States
- TBHC United States
- Employees
- CLNN N/A
- TBHC N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- TBHC Other Specialty Stores
- Sector
- CLNN Health Care
- TBHC Consumer Discretionary
- Exchange
- CLNN Nasdaq
- TBHC Nasdaq
- Market Cap
- CLNN 23.1M
- TBHC 27.6M
- IPO Year
- CLNN N/A
- TBHC N/A
- Fundamental
- Price
- CLNN $3.82
- TBHC $1.24
- Analyst Decision
- CLNN Strong Buy
- TBHC
- Analyst Count
- CLNN 5
- TBHC 0
- Target Price
- CLNN $40.00
- TBHC N/A
- AVG Volume (30 Days)
- CLNN 70.5K
- TBHC 406.0K
- Earning Date
- CLNN 08-19-2025
- TBHC 09-04-2025
- Dividend Yield
- CLNN N/A
- TBHC N/A
- EPS Growth
- CLNN N/A
- TBHC N/A
- EPS
- CLNN N/A
- TBHC N/A
- Revenue
- CLNN $350,000.00
- TBHC $431,111,000.00
- Revenue This Year
- CLNN N/A
- TBHC N/A
- Revenue Next Year
- CLNN $1,753.57
- TBHC N/A
- P/E Ratio
- CLNN N/A
- TBHC N/A
- Revenue Growth
- CLNN N/A
- TBHC N/A
- 52 Week Low
- CLNN $2.28
- TBHC $1.20
- 52 Week High
- CLNN $6.90
- TBHC $1.73
- Technical
- Relative Strength Index (RSI)
- CLNN 55.42
- TBHC N/A
- Support Level
- CLNN $3.30
- TBHC N/A
- Resistance Level
- CLNN $3.93
- TBHC N/A
- Average True Range (ATR)
- CLNN 0.23
- TBHC 0.00
- MACD
- CLNN 0.02
- TBHC 0.00
- Stochastic Oscillator
- CLNN 82.61
- TBHC 0.00
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.